Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson’s disease

References

• Traynelis SF Wollmuth LP McBain CJ Glutamate receptor ion channels: structure, regulation, and function Pharmacol Rev 2010 62 3 405 496 20716669
   PubMed Web of Science ®Google Scholar
• Dingledine R Borges K Bowie D Traynelis SF The glutamate receptor ion channels Pharmacol Rev 1999 51 1 7 61 10049997
   PubMed Web of Science ®Google Scholar
• Kew JN Kemp JA Ionotropic and metabotropic glutamate receptor structure and pharmacology Psychopharmacology (Berl) 2005 179 1 4 29 15731895
   PubMed Web of Science ®Google Scholar
• Standaert DG Testa CM Young AB Penney JB Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat J Comp Neurol 1994 343 1 1 16 8027428
   PubMed Web of Science ®Google Scholar
• Loftis JM Janowsky A The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications Pharmacol Ther 2003 97 1 55 85 12493535
   PubMed Web of Science ®Google Scholar
• Tarazi FI Campbell A Yeghiayan SK Baldessarini RJ Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors Synapse 1998 30 2 227 235 9723793
   PubMed Web of Science ®Google Scholar
• Zavitsanou K Mitsacos A Giompres P Kouvelas ED Changes in [3H] AMPA and [3H]kainate binding in rat caudate-putamen and nucleus accumbens after 6-hydroxydopamine lesions of the medial forebrain bundle: an autoradiographic study Brain Res 1996 731 1–2 132 140 8883863
   PubMed Web of Science ®Google Scholar
• Lai SK Tse YC Yang MS Wong CK Chan YS Yung KK Gene expression of glutamate receptors GluR1 and NR1 is differentially modulated in striatal neurons in rats after 6-hydroxydopamine lesion Neurochem Int 2003 43 7 639 653 12892651
   PubMed Web of Science ®Google Scholar
• Nandhu MS Paul J Kuruvila KP Abraham PM Antony S Paulose CS Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson’s rat: functional recovery with bone marrow cells, serotonin and GABA Mol Cell Biochem 2011 353 1–2 47 57 21384157
   PubMed Web of Science ®Google Scholar
• Ng OT Chen LW Chan YS Yung KK Small interfering RNA specific for N-methyl-D-aspartate receptor 2B offers neuroprotection to dopamine neurons through activation of MAP kinase Neurosignals 2013 21 1–2 42 54 22377595
   PubMedGoogle Scholar
• Dunah AW Wang YH Yasuda RP Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson’s disease Mol Pharmacol 2000 57 2 342 352 10648644
   PubMed Web of Science ®Google Scholar
• Gardoni F Picconi B Ghiglieri V A critical int eraction between NR2B and MAGUK in L-DOPA induced dyskinesia J Neurosci 2006 26 11 2914 2922 16540568
   PubMed Web of Science ®Google Scholar
• Kong M Ba M Song L Liu Z Comparative effects of acute or chronic administration of levodopa to 6-OHDA–lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in the striatum Neurochem Res 2009 34 8 1513 1521 19283475
   PubMed Web of Science ®Google Scholar
• Fiorentini C Rizzetti MC Busi C Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat Mol Pharmacol 2006 69 3 805 812 16365282
   PubMed Web of Science ®Google Scholar
• Paxinos G Watson C The Rat Brain in Stereotaxic Coordinates 6th ed London, UK Academic Press/Elsevier 2007
   Google Scholar
• Ye M Wang XJ Zhang YH Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson’s disease Brain Res 2007 1142 206 216 17336273
   PubMed Web of Science ®Google Scholar
• Wang XJ Liu WG Zhang YH Lu GQ Chen SD Effect of transplantation of c17.2 cells transfected with interleukin-10 gene on intracerebral immune response in rat model of Parkinson’s disease Neurosci Lett 2007 423 2 95 99 17673368
   PubMed Web of Science ®Google Scholar
• Mao LM Wang W Chu XP Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine Nat Neurosci 2009 12 5 602 610 19349975
   PubMed Web of Science ®Google Scholar
• Boudreau AC Milovanovic M Conrad KL Nelson C Ferrario CR Wolf ME A protein cross-linking assay for measuring cell surface expression of glutamate receptor subunits in the rodent brain after in vivo treatments Curr Protoc Neurosci 2012 Chapter 5 Unit 5.30.1 Unit 5.3019
   Google Scholar
• Carino C Fibuch EE Mao LM Wang JQ Dynamic loss of surface-expressed AMPA receptors in mouse cortical and striatal neurons during anesthesia J Neurosci Res 2012 90 1 315 323 21932367
   PubMed Web of Science ®Google Scholar
• Boudreau AC Wolf ME Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens J Neurosci 2005 25 40 9144 9151 16207873
   PubMed Web of Science ®Google Scholar
• Blandini F Armentero MT Martignoni E The 6-hydroxydopamine model: news from the past Parkinsonism Relat Disord 2008 14 Suppl 2 S124 S129 18595767
   PubMedGoogle Scholar
• Simola N Morelli M Carta AR The 6-hydroxydopamine model of Parkinson’s disease Neurotox Res 2007 11 3–4 151 167 17449457
   PubMed Web of Science ®Google Scholar
• Wang YT Salter MW Regulation of NMDA receptors by tyrosine kinases and phosphatases Nature 1994 369 6477 233 235 7514272
   PubMed Web of Science ®Google Scholar
• Truong L Allbutt HN Coster MJ Kassiou M Henderson JM Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions Brain Res Bull 2009 78 2–3 91 96 19007866
   PubMed Web of Science ®Google Scholar
• Rao VL Bowen KK Dempsey RJ Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain Neurochem Res 2001 26 5 497 502 11513475
   PubMed Web of Science ®Google Scholar
• Nandhu MS Paul J Kuruvilla KP Malat A Romeo C Paulose CS Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson’s rats: effect of 5-HT, GABA and bone marrow cell supplementation J Biomed Sci 2011 18 5 21235809
   PubMed Web of Science ®Google Scholar
• Löschmann PA De Groote C Smith L Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson’s disease Exp Neurol 2004 187 1 86 93 15081591
   PubMed Web of Science ®Google Scholar
• Liu Y Wong TP Aarts M NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo J Neurosci 2007 27 11 2846 2857 17360906
   PubMed Web of Science ®Google Scholar
• Lai SK Ng TK Lau WK Selective knockdown of gene expression of N-methyl-D-aspartate receptor one ameliorates Parkinsonian motor symptom in 6-hydroxydopamine-lesioned rats Neurochem Int 2004 45 1 11 22 15082217
   PubMed Web of Science ®Google Scholar
• Sze SC Wong CK Yung KK Modulation of the gene expression of N-methyl-D-aspartate receptor NR2B subunit in the rat neostriatum by a single dose of specific antisense oligodeoxynucleotide Neurochem Int 2001 39 4 319 327 11551672
   PubMed Web of Science ®Google Scholar
• Johnson KA Conn PJ Niswender CM Glutamate receptors as therapeutic targets for Parkinson’s disease CNS Neurol Disord Drug Targets 2009 8 6 475 491 19702565
   PubMed Web of Science ®Google Scholar
• Addy C Assaid C Hreniuk D Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson’s disease J Clin Pharmacol 2009 49 7 856 864 19491335
   PubMed Web of Science ®Google Scholar